Subjective attitude to risperidone long-acting injectable (RLAI): Results from a long-term Italian study in subjects with schizophrenia or schizoaffective disorder

被引:0
作者
Rossi, A. [1 ]
Bernareggi, M. M. [2 ]
Giustra, M. G. [2 ]
机构
[1] Univ Laquilo, Dept Expt Med, Laquila, Italy
[2] Janssen Cilag SpA, Risperidone Long Acting Trial Italian Invest, Med Affairs, Milan, Italy
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:S167 / S167
页数:1
相关论文
共 3 条
  • [1] Remission in schizophrenia: Proposed criteria and rationale for consensus
    Andreasen, NC
    Carpenter, WT
    Kane, JM
    Lasser, RA
    Marder, SR
    Weinberger, DR
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (03) : 441 - 449
  • [2] A SELF-REPORT SCALE PREDICTIVE OF DRUG COMPLIANCE IN SCHIZOPHRENICS - RELIABILITY AND DISCRIMINATIVE VALIDITY
    HOGAN, TP
    AWAD, AG
    EASTWOOD, R
    [J]. PSYCHOLOGICAL MEDICINE, 1983, 13 (01) : 177 - 183
  • [3] Rossi A, 2001, Epidemiol Psichiatr Soc, V10, P107